Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for 10x Genomics (TXG : NSDQ)

• Company Description    10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. Number of Employees: 473

• Price / Volume Information    Yesterday's Closing Price: $46.27 Daily Weekly Monthly 20 Day Moving Average: 3,178,708 shares Shares Outstanding: 126.96 (millions) Market Capitalization: $5,874.25 (millions) Beta: 2.05 52 Week High: $49.50 52 Week Low: $11.18 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 29.50% 28.55% 12 Week 109.84% 104.10% Year To Date 183.69% 172.28%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6230 STONERIDGE MALL ROAD - PLEASANTON,CA 94588 USA ph: 925-401-7300 fax: - investors@10xgenomics.com http://www.10xgenomics.com

• General Corporate Information    Officers Serge Saxonov - Chief Executive Officer and Director John R. Stuelpnagel - Chairman Benjamin J. Hindson - President Adam S. Taich - Chief Financial Officer Sridhar Kosaraju - Director Peer Information 10x Genomics (HLIS) 10x Genomics (AZTA) 10x Genomics (APYI) 10x Genomics (RNVA) 10x Genomics (HMSY) 10x Genomics (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 88025U109 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 126.96 Most Recent Split Date: (:1) Beta: 2.05 Market Capitalization: $5,874.25 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.26 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.78 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 58.74% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.76 Price/Cash Flow: - Price / Sales: 9.20 EPS Growth vs. Year Ago Period: 72.22% vs. Previous Quarter: 23.08% Sales Growth vs. Year Ago Period: -2.61% vs. Previous Quarter: -9.15% ROE 06/30/26 - - 03/31/26 - -2.86 12/31/25 - -6.89 ROA 06/30/26 - - 03/31/26 - -2.23 12/31/25 - -5.34 Current Ratio 06/30/26 - - 03/31/26 - 5.90 12/31/25 - 4.46 Quick Ratio 06/30/26 - - 03/31/26 - 5.42 12/31/25 - 4.09 Operating Margin 06/30/26 - - 03/31/26 - -3.55 12/31/25 - -8.21 Net Margin 06/30/26 - - 03/31/26 - -3.55 12/31/25 - -6.77 Pre-Tax Margin 06/30/26 - - 03/31/26 - -3.01 12/31/25 - -6.21 Book Value 06/30/26 - - 03/31/26 - 6.85 12/31/25 - 6.24 Inventory Turnover 06/30/26 - - 03/31/26 - 3.23 12/31/25 - 3.04 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©